Companies / Atea Pharmaceuticals, Inc. / Activity
Activity — Atea Pharmaceuticals, Inc.
6 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 31, 2026 | Sommadossi Jean-Pierre CEO | Other | Common Stock | $449.8K | -106K -18.49% | 467,830 0.58% of shares | low |
| Feb 3, 2026 | Sommadossi Jean-Pierre CEO | Exercise | Common Stock | $372.0K | +300K +64.13% | 767,830 0.96% of shares | low |
| Feb 3, 2026 | Sommadossi Jean-Pierre CEO | Exercise | Stock Option (Right to Buy) | — | -300K -100.00% | 0 0.00% of shares | low |
| Jan 31, 2026 | Sommadossi Jean-Pierre CEO | Exercise | Restricted Stock Units | — | -100K -100.00% | 0 0.00% of shares | low |
| Jan 31, 2026 | Sommadossi Jean-Pierre CEO | Exercise | Restricted Stock Units | — | -173K -100.00% | 0 0.00% of shares | low |
| Jan 31, 2026 | Sommadossi Jean-Pierre CEO | Exercise | Common Stock | — | +273K +90.71% | 573,923 0.72% of shares | low |